As part of the activities of the GUMed Technology Transfer Centre, one of the most important stages in supporting innovation development is the substantive evaluation of pre-implementation projects. This process lays the foundation for further cooperation and determines the direction in which the project will be developed and brought to the market.
Pre-implementation projects are initiatives aimed at taking research results to the stage where they can be applied in practice. This includes not only technology development, but also testing, market analysis and planning the commercialisation process. Our support for such projects enables the effective translation of scientific research results into tangible products, services or solutions that can contribute to the growth of a knowledge-based economy.
The substantive evaluation is a key moment during which the project is thoroughly analysed for its feasibility, innovativeness, market potential and alignment with user needs. The evaluation is based on specific criteria covering the following aspects of the project
Innovation and originality: The extent to which the project introduces a new quality compared to existing market solutions.
Technological feasibility: Whether the technology or solution can be implemented under market conditions and what potential risks are associated with its realisation.
Market potential: The commercialisation prospects of the technology and the market need that the project aims to address.
Project team: The skills and experience of the people responsible for carrying out the project.
Expected socio-economic benefits: The positive impact the project will have locally, nationally or globally.
A thorough substantive evaluation allows the selection of the most promising projects with real potential for market success. This process makes it possible to direct financial and advisory support to projects that are likely to contribute to the development of a modern economy. Our goal is to support innovations that can make a real impact on improving quality of life, advancing medicine, and introducing new, groundbreaking solutions to the market.